COVID-19 clinical outcomes and DMT of MS patients and population-based controls.
Longinetti E, Bower H, McKay KA, Englund S, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Mellergård J, Olsson T, Piehl F, Frisell T.
Longinetti E, et al. Among authors: burman j.
Ann Clin Transl Neurol. 2022 Sep;9(9):1449-1458. doi: 10.1002/acn3.51646. Epub 2022 Aug 22.
Ann Clin Transl Neurol. 2022.
PMID: 35993445
Free PMC article.